Grezier's slow release boosts early phase insulin secretion to effectively control blood sugar for 24 hours

Grezierte slow release tablet (Delta Kang slow release tablets) due to the characteristics of hydrophilic matrix, after oral 1 can effectively control 24 hours of blood sugar levels, especially during the day blood concentration is high, can be a good control of blood sugar, and the concentration of blood at night is relatively low, so can reduce the possibility of hypoglycemia at nightTherefore, Delta Can adjust the release of drugs, in line with the needs of diabetic seisac blood sugar control 24 hoursPast studies have shown that people with diabetes not only have good blood sugar control, but also have little fluctuations in blood sugar after meals after taking 30 to 120 mg/d treatmentStudies have shown that Delta Can's slow release can promote insulin secretion in early stages and thus help lower blood sugar levels after mealsThe Survey of the Secretion of Insulin in China (CISS), led by Professor Li Guangweiof the Sino-Japanese FriendshipHospital of the Ministry of Health, is a multi-centered, open and forward-looking studyThe study included 120 cases of adult type 2 diabetes, and was designed to see if patients could improve insulin secretion and significantly reduce blood sugar after taking The Damecon searly release tablets, including 10 patientsat Peking University's FirstHospitalThe results showed that patients had significantly improved blood sugar on an empty stomach or after meals after treatment, and that the average level of glycated hemoglobin (HbA1c) in all patients decreased significantly compared to pre-treatment, regardless of whether they met the standardThe area under the insulin curve for 30 minutes after each patient's meal after treatment increased significantly compared to the pre-treatment area (P.026)The results showed that Delta's slow release tablets significantly increased insulin early phase secretion, which continued 48 hours after discontinuation, and that HbA1c levels were significantly improved as a resultThe results show that The Damecon slow release tablet 1 oral can effectively reduce fasting blood sugar, post-meal blood sugar and HbA1c, while restoring early insulin phase secretionThe meeting concluded, although there is also insulin resistance in Patients with T2DM in China, but still with insulin secretion defects more common, sulfonylurea drugs such as DeltaCom slow release tablets as insulin progenitor drugs, can be a good improvement of early insulin phase secretion, the effect of sugar reduction is ideal, sulfonyne drugs are still the cornerstone of the treatment of T2DM; T2DM patients receive long-term enhanced multi-factor intervention treatment can benefit long-term, and in the course of treatment, physicians continue to encourage patients to treat is very important,, clinical trial results and practice salways there are some differences, but we should implement the concept of the results of the trial into clinical practice, and encourage the implementation of the community, if this can be done, the cost-benefit ratio is greatest(Gao)